Chronic Mucocutaneous Candidiasis
- 1 March 1979
- journal article
- research article
- Published by American Medical Association (AMA) in Archives of Dermatology
- Vol. 115 (3) , 322-323
- https://doi.org/10.1001/archderm.1979.04010030030011
Abstract
Treatment of chronic mucocutaneous candidiasis has included drugs, immunotherapy, and replacement of nutritional and endocrine deficiency. Although amphotericin B is the best known and most commonly used form of treatment, the imidazole antibiotic clotrimazole has shown promise as an effective agent that can be given orally with low toxicity. A 9-year-old girl responded to intermittent clotrimazole therapy with complete and prolonged remission. This form of treatment offers advantages in safety and effectiveness over other therapies for chronic mucocutaneous candidiasis. (Arch Dermatol 115:322-323, 1979)Keywords
This publication has 9 references indexed in Scilit:
- Chronic muco-cutaneous candidiasis: new approaches to treatmentBritish Journal of Dermatology, 2006
- Treatment of Chronic Mucocutaneous CandidiasisAnnals of Internal Medicine, 1977
- Clotrimazole treatment of chronic mucocutaneous candidiasisThe Journal of Pediatrics, 1976
- Successful Treatment of Systemic Candidiasis Following Cardiac SurgeryArchives of Pediatrics & Adolescent Medicine, 1974
- Clotrimazole (Bay b 5097): In Vitro and Clinical Pharmacological StudiesAntimicrobial Agents and Chemotherapy, 1972
- Laboratory assessment of the antimycotic drug clotrimazoleJournal of Clinical Pathology, 1972
- Successful treatment of Candida septicaemia in severely burned patients with a new antimycotic, Clotrimazole (Bay b 5097)Injury, 1972
- C. albicans resistance to 5-fluorocytosine.BMJ, 1972
- Treatment of chronic mucocutaneous candidiasis of children (Candida granuloma) with clotrimazoleArchives of Dermatological Research, 1972